Share on StockTwits
 

Imperva (NASDAQ: IMPV) received a number of ratings updates from brokerages and research firms in the last week:

  • Imperva had its price target raised by analysts at Oppenheimer from $55.00 to $59.00. They now have an “outperform” rating on the stock.
  • Imperva is now covered by analysts at Sterne Agee. They set a “neutral” rating on the stock.
  • Imperva had its price target raised by analysts at RBC Capital from $54.00 to $60.00. They now have an “outperform” rating on the stock.
  • Imperva had its price target raised by analysts at BMO Capital Markets from $52.00 to $57.00.
  • Imperva had its price target raised by analysts at Wedbush from $47.00 to $51.00.
  • Imperva had its price target raised by analysts at Pacific Crest from $57.00 to $62.00.
  • Imperva had its price target raised by analysts at Imperial Capital from $53.00 to $65.00. They now have an “outperform” rating on the stock.
  • Imperva was downgraded by analysts at Zacks from a “neutral” rating to an “underperform” rating. They now have a $56.30 price target on the stock.

Shares of Imperva Inc (NASDAQ:IMPV) traded up 0.57% on Wednesday, hitting $58.35. The stock had a trading volume of 169,468 shares. Imperva Inc has a 52 week low of $35.00 and a 52 week high of $60.44. The stock has a 50-day moving average of $53.39 and a 200-day moving average of $46.44. The company’s market cap is $1.443 billion.

Imperva, Inc (NASDAQ:IMPV) is engaged in providing data security solutions focused on providing visibility and control over business data across systems within the data center.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.